Regula, J. T., & Koss, M. J. (2016). Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO molecular medicine, 8(11), . https://doi.org/10.15252/emmm.201505889
Chicago-Zitierstil (17. Ausg.)Regula, Jörg Thomas, und Michael Janusz Koss. "Targeting Key Angiogenic Pathways with a Bispecific CrossMAb Optimized for Neovascular Eye Diseases." EMBO Molecular Medicine 8, no. 11 (2016). https://doi.org/10.15252/emmm.201505889.
MLA-Zitierstil (9. Ausg.)Regula, Jörg Thomas, und Michael Janusz Koss. "Targeting Key Angiogenic Pathways with a Bispecific CrossMAb Optimized for Neovascular Eye Diseases." EMBO Molecular Medicine, vol. 8, no. 11, 2016, https://doi.org/10.15252/emmm.201505889.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.